C-Reactive Protein Levels and Clinical Symptoms Following Gadolinium Administration in Hemodialysis Patients
To access this article, please choose from the options below
PII: S0272-6386(08)00529-5
doi:10.1053/j.ajkd.2008.02.299
© 2008 National Kidney Foundation, Inc. Published by Elsevier Inc All rights reserved.
Refers to article:
- Gadolinium-Containing Magnetic Resonance Imaging Contrast and Nephrogenic Systemic Fibrosis: A Case-Control Study , 26 March 2008
